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adolescent and young adult rheumatology
services (BeTAR)
Ran A. Cai1* , Hema Chaplin2, Polly Livermore1,3,4, Martin Lee5, Debajit Sen1,6, Lucy R. Wedderburn1,4,7,
Nick Wilkinson8, Rachel Jeffery9, Andrea Kempa9, Imogen Norton9, Rachel Tattersall10, Yiannis Ioannou6 and
Despina Eleftheriou1,4,7
Abstract
Background: Young people (YP; 12–24 years old) with rheumatic diseases face many challenges associated with chronic
illness in addition to the physiological and psychosocial changes of adolescence. Timely access to developmentally
appropriate multidisciplinary care is key to successfully managing rheumatic diseases, but gaps in the care of this
vulnerable age group still exist. This study aimed to develop a benchmarking toolkit to enable comparative evaluation of
YP rheumatology services in order to promote best practice and reduce variations in service delivery.
Methods: A staged and consultative method was used across a broad group of stakeholders in the UK (YP, parents/other
carers, and healthcare professionals, HCPs) to develop this toolkit, with reference to pre-existing standards of YP-friendly
healthcare. Eighty-seven YP (median age 19 years, range 12–24 years) and 26 rheumatology HCPs with 1–34 years of
experience caring for YP have participated.
Results: Thirty quality criteria were identified, which were grouped into four main domains: assessment and treatment,
information and involvement, accessibility and environment, and continuity of care. Two toolkit versions, one to be
completed by HCPs and one to be completed by patients, were developed. These were further refined by relevant
groups and face validity was confirmed.
Conclusions: A toolkit has been developed to systematically evaluate and benchmark YP rheumatology services, which is
key in setting standards of care, identifying targets for improvement and facilitating research. Engagement from YP,
clinical teams, and commissioners with this tool should facilitate investigation of variability in levels of care and drive
quality improvement.
Keywords: Adolescent rheumatology, Standards of care, Benchmarking, Quality improvement, Healthcare services, Patient
involvement, Toolkit
Background
Advances in the field of paediatric and adolescent
rheumatology over the past decade have decreased
long-term morbidity and mortality rates [1]. This has
resulted in a greater number of children with rheumatic
diseases surviving into adulthood and having to negotiate
transitions into adult services. As young people (YP)
transfer from paediatric to adult rheumatology care, they
need to develop an executive suite of skills including
autonomy, resilience and self-management [2, 3]. This
occurs in parallel to the immense physiological and
psychosocial developmental changes that challenge all YP
[4, 5]. Better organised services are therefore required to
address the specific needs of this population.
Appropriately tailored interventions and healthcare
provision remain central to minimizing the adverse
impact of rheumatic diseases on physical and visual
functions, psychosocial adjustments, general quality of
life, as well as educational attainments during this
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vulnerable time. Failing to meet the needs of YP and
families may negatively impact YP’s health and lead to
disengagement with healthcare services [2, 6–8]. Disap-
pointingly, unmet needs of YP with rheumatic diseases and
gaps in care, particularly at transfer to adult healthcare
provision, are still reported worldwide [9–11]. This is
despite published guidelines for how to provide YP-friendly
services [12–18] and the solid evidence base supporting the
positive outcomes of planned and individualised develop-
mentally appropriate care for YP [2, 6–8].
A number of previous recommendations outlined
quality standards and performance measures that are
specifically relevant to YP with juvenile-onset rheumatic
diseases have either focused on transitional care [19, 20]
or on specialised medical care guidelines for juvenile
idiopathic arthritis (JIA) [21–24]. Efforts to measure care
quality have also resulted in the development of generic
self-assessment tools to evaluate standards of care for
YP, two of which are endorsed by key professional bodies
in the UK: 1) the You’re Welcome (YW) self-review tool
that is applicable to various healthcare settings [25] and 2)
the condition-specific tool for measuring Standards of
Care (SOC) for Children and Young People with JIA [26].
Both YW and SOC tools provide a set of statements/ques-
tions to help service providers evaluate how well they are
meeting various domains of YP-friendly care.
However, the majority of these previously published
guidelines are descriptive rather than providing a quantita-
tive assessment to allow for comparative service evalua-
tions. In addition, previously developed tools may not be
applicable to all YP living with different types of chronic
inflammatory rheumatic diseases [21, 25]. It is thus essen-
tial to develop a benchmarking toolkit that can evaluate
adolescent and young adult rheumatology services in
order to promote best practice and reduce current varia-
tions in service delivery for this age group. The aim of this
project was therefore to develop a comprehensive bench-
marking toolkit for adolescent and young adult rheuma-
tology services (BeTAR) that is applicable across both
paediatric and adult services. BeTAR was developed in
partnership with YP and under the auspices of the Barbara
Ansell National Network of Adolescent Rheumatology, a
network of adult and paediatric healthcare professionals
(HCPs) caring for YP with rheumatic diseases across the
UK. This toolkit will first enable evaluations of current
clinical practice of YP rheumatology services in the UK
before implementing it internationally.
Participants and methods
BeTAR was developed and refined using an iterative
process over five phases by combining findings from pre-
vious literature with results from focus groups (FGs),
semi-structured interviews, and surveys from YP, parents/
other carers, and HCPs (Fig. 1). A maximum variation
sampling method was used to recruit participants to
account for a wide range of backgrounds and experiences.
We aimed to maximise engagement by offering different
ways of data collection through both face-to-face and
online methods. All participants could take part in
multiple phases of the study. The study was granted ethics
approval by the Office for Research Ethics Committees
Northern Ireland (REC15/NI/0207) and informed consent
and assent were obtained. The study was registered on the
National Institute of Health Research portfolio of
non-commercial studies (study ID: 19980).
Phase 1: Literature review to define standards of care for
rheumatology YP-friendly services
A systematic literature search was performed to establish
any published standards or assessments for YP-friendly
rheumatology services. All publications until June 2018
from four popular databases (PubMed, CINAHL,
EMBase, and Web of Science) were searched. Initial
search terms were obtained from MeSH (Medical Subject
Heading) nomenclature and then mapped to appropriate
database-specific terminology from selected publications
(Table 1). Papers matching any combination of terms from
the four concept areas in title, subject, keyword, and full
text were retrieved for review. In addition, we searched
websites of respected professional organisations for pub-
lished guidelines and recommendations for YP’s health-
care to screen for additional standards. These included the
following: Arthritis and Musculoskeletal Alliance
(ARMA), British Society for Rheumatology (BSR/BSPAR),
European League Against Rheumatism (EULAR), Paediat-
ric Rheumatology European Society (PReS), American
College of Rheumatology (ACR), Royal Australian College
of General Practitioners (RACGP), Canadian Rheumatol-
ogy Association (CRA), National Institute for Health and
Care Excellence (NICE) and Department of Health and
Social Care (DHSC).
Studies looking at quality of care for YP-friendly
rheumatology services written in English were identified
(Fig. 2). Studies were excluded if they were not generic
and focused specifically on chronic conditions that are not
related to rheumatology. From these data, quality stan-
dards for YP-friendly services that are relevant for
rheumatology care were reviewed by the core study team
(RAC, DE, RT and YI). This helped define themes relating
to what constitutes good healthcare provision for YP.
Phase 2: Toolkit item development and ranking in
partnership with adolescents and young adults
YP (12–24 years old) with chronic inflammatory rheum-
atic diseases cared for at a pediatric, adolescent and
young adult rheumatology hospital unit in London were
approached to take part in the study for a mixture of
FGs and one-to-one interviews. All sessions were
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conducted, taped, and transcribed by the same re-
searcher (RAC), who was not involved in participants’
clinical care. YP’s thoughts on these previously published
standards of care were explored. They were asked what
criteria need to be met by a service to provide the best
possible care, and whether they felt any new standards
or areas of care needed to be considered. Lastly, YP were
asked to generate specific questions and response items
for each criterion. As a result of this process, the toolkit
developed comprised of two versions, one to be com-
pleted by HCPs and one to be completed by YP (Fig. 3).
This procedure was repeated until saturation was
reached and no new information and further criteria
were suggested from YP [27]. The structure of the FGs
and in-depth interviews are shown in Additional file 1. YP
were then asked to prioritise all criteria based on their
order of importance using a diamond ranking exercise,
and each criterion was assigned a rank-order based on
their ranked position [28]. YP also rated each criteria on a
5-point scale (1 = not important at all, 5 = very important).
Phase 3: Toolkit item evaluation by HCPs
A multidisciplinary group of rheumatology HCPs
reviewed the standards and rank-order assigned by
YP. The process was completed through online
surveys, followed by a face to face consensus meeting.
Key areas covered were comprehensiveness, clarity,
relevance, and feasibility of use for the proposed HCP
Table 1 Literature search strategy
Concept area keywords Search PubMed EMBase Web of
Science
Professional
organisations
A “young adult*”, adolescent*, youth, teen* A 475
B transition*, service*, healthcare, “health care”, care [A and B and
C and D]
3586a 2349a 480
C quality*, model*, indicator*, standard*, tool*, evaluation*, benchmark*, criteria,
guideline*, assessment*, measure*, recommendation*, performance*
D arthritis, “lupus erythematosus”, scleroderma, vasculitis, dermatomyositis,
dermatopolymyositis, polymyositis)
Retrieved for review process 67 80 192 11
a Top 500 hits (sorted by relevance) reviewed for inclusion
Fig. 1 Study phases for developing BeTAR
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toolkit. If ≥80% of HCPs endorsed a proposed stand-
ard or a way of combining multiple criteria, then this
standard was included in the toolkit. If a criterion
reached < 80% consensus it was discussed in the next
phase with YP. These thresholds were also used to
evaluate the question and response items, as well as
the rank-order of each criterion. Lastly, HCPs were
asked about the challenges of using the toolkit in
practice.
Phase 4: Accounting for multi-site variation and
proposing a scoring system defined by YP
Phase 4 aimed to refine the toolkit by accounting for any
multi-site variation, and to develop a quantitative scoring
system. YP and their parents/carers were recruited from
rheumatology outpatient’s clinics in Sheffield, Newcastle,
Northampton, and London to participate in either FGs or
one-to-one interviews. We chose these places to maximize
variations in participants’ experiences by involving health
Fig. 2 Literature search and review process
Fig. 3 BeTAR structure
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services from larger, more ethnically diverse cities where
less than 60% of the population are from the White ethnic
group (London), as well as from smaller, less diverse cities
with a more than 80% (Newcastle and Northampton) and
90% (Sheffield) of the population from the White ethnic
group.
The 1000minds software [29], which is a decision-mak-
ing program using the Potentially All Pairwise RanKings
of all possible Alternatives (PAPRIKA) method [30], was
used to develop the scoring system for both versions of
the toolkit. Participants were first asked to review the
toolkit’s content and were then given repeated compari-
sons between two service criteria through 1000minds.
They were asked to choose which of the two service cri-
teria is more important or whether they are equally im-
portant (Fig. 4). Each criterion received a ‘preference
value’ according to the PAPRIKA method; criteria with
greater importance received higher preference values and
were thus assigned more points than criteria with lower
preference values.
During this process, the rank-order of each criterion
proposed by YP in phase 2 and by HCPs in phase 3 were
also discussed to encourage YP to reassess their judge-
ments in light of the comments and feedback provided
by other participants [31]. Relative weights of the criteria
were used to develop a scoring system such that when
all item responses are considered together, the max-
imum score possible for each version of the toolkit is
100 and the minimum score is 0.
Phase 5: Cognitive interviews to evaluate face validity
and usability
Phase 5 aimed to evaluate face validity and test the us-
ability of the toolkit through individual cognitive
interviews (CI). Sample size used for cognitive interviews
are normally small, and five participants can be sufficient
[32–35]. Purposeful sampling [36] was used to ensure
HCPs from various rheumatology centres and YP with
diverse disease characteristics and demographics were
included. Participants were interviewed in person or
over the telephone. A mixture of think-aloud and verbal
probing techniques were used in order to gain maximal
information and to encourage participants to talk about
any words or concepts that they found troublesome (see
Additional file 2) [34, 35]. For any item that participants
judged as ‘medium’ or ‘hard’ to understand, they were
asked to suggest ways to reword the item to improve
comprehension. The data gathered were used to modify
and improve question items and response choices.
Data analysis
Qualitative responses from FGs and one-to-one inter-
views were taped, transcribed, and analysed using con-
tent analysis to identify key themes and categories [37].
To reduce the chance of bias, transcripts were reviewed
by two researchers (RAC and DE) to identify major
themes [38]. Differences were resolved by discussions
with two more researchers (YI and HC) until consensus
was reached. Data analysis was carried out using NVivo
software [39] for coding data with similar contents into
meaningful categories and overarching themes. In
addition, content analysis was performed according to
centre and age group (12–15 years and 16–24 years).
Results
Participants
Out of 95 YP who were approached, eight did not par-
ticipate either because they did not have time (n = 3) or
Fig. 4 Example of a pairwise-ranking question from the 1000Minds conjoint-analysis survey
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were not interested (n = 5). A total of 87 YP (21 males)
aged 12–24 with rheumatic diseases and five parents/
carers of YP participated in the study (Table 2). The
median age of diagnosis was 10.5 (range 1–16) and
median disease duration was 9 years (range 1–22).
Out of 29 rheumatology HCPs who were approached
for the study, 26 agreed to take part. The median
number of experience in adolescent rheumatology was
11 years (range 1–34).
Phase 1: Summary of literature review defining standards
of optimal care for rheumatology YP-friendly services
The literature search identified 1953 articles; after
screening for full text and duplicates, 285 articles
remained. In total, 48 distinct criteria pertaining to qual-
ity of healthcare services for YP in rheumatology ser-
vices were extracted from these articles and were
grouped into 6 themes: provision of information or edu-
cation, preparation for transition to adulthood, staff
expertise/support, YP involvement, service efficiency,
and service accessibility. All these themes were discussed
with YP in the following phases.
Phase 2: Developing and ranking items based on FGs and
interviews with YP
Two FGs (n1 = 5, n2 = 3) and 30 one-to-one interviews
were conducted with YP. During this phase, YP sug-
gested 17 new criteria that included: providing specific
pain-management information; self-injection of metho-
trexate taught by a rheumatology nurse; and sharing and
explaining test/assessment results (e.g., blood tests). All
17 of these new criteria proposed by YP, as well as all
the criteria and standards derived from previous litera-
ture, are listed in Additional file 3. The five most
important criteria according to YP were: HCPs’ expert-
ise/knowledge in adolescent rheumatology, accessing
effective therapies and treatments; timely access to treat-
ments; monitoring symptoms, and accessing urgent
Table 2 Demographic characteristics of YP and HCPs included in the study
Phase 2 Phase 3 Phase 4 Phase 5
Total no. of YPa, n 38 27 28
Age
Median in years (range) 19 (15–24) 18 (12–24) 19 (12–24)
Mean in years (SD) 19.1 (2.7) 18.5 (3) 18.8 (3.1)
Age of diagnosis
Median in years (range) 10 (1–16) 10 (1–16) 10.5 (2–15)
Mean in years (SD) 9.5 (4.4) 9.4 (4.8) 10 (3.8)
Sex
Female, n (%) 31 (82) 18 (67) 17 (61)
Male, n (%) 7 (18) 9 (33) 11 (39)
Ethnicity
White, n (%) 24 (63) 17 (63) 18 (64)
Asian, n (%) 9 (24) 5 (19) 7 (25)
Black, n (%) 3 (8) 3 (11) 3 (7)
Other, n (%) 2 (5) 2 (7) 2 (4)
Type of diagnosis
JIA, n (%) 27 (71) 20 (74) 17 (61)
JSLE, n (%) 7 (18) 4 (15) 4 (14)
JDM, n (%) 4 (11) 3 (11) 7 (25)
Total no. of HCPsb, n 22 7
Clinician, n (%) 16 (73) 5 (71)
Clinical nurse specialists, n (%) 5 (23) 2 (29)
Physiotherapist, n (%) 1 (4) 0
Years in practice
Median (range) 10.5 (1–34) 11 (3–34)
Mean (SD) 13.3 (9.3) 14.5 (8.9)
a Six YP took part in multiple phases of the study
b Three HCPs took part in multiple phases of the study
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consultations. All 65 criteria were included in the pre-
liminary version of the toolkit. YP also generated a list
of questions and response items to define and assess
each criterion. Moreover, YP suggested a YP version of
the toolkit to assess the quality of care from the patient’s
perspective.
Phase 3: Further toolkit refinement and evaluation by
HCPs
Fourteen HCPs participated in an online survey and
eight HCPs attended the consensus meeting. The group
agreed on 18 of the original criteria to be included in
the toolkit and 42 original criteria were combined into
13 new criteria. For example, providing out-of-hour
appointments and phone/skype consultations were com-
bined into one inclusive criterion for “convenient
appointments”. Five criteria were excluded as they were
ranked low in importance by YP and > 80% of the HCPs
voted in favour of excluding them. These were: provid-
ing information on nutrition, providing information on
alcohol and drugs, providing information on sexual
health, accessibility for patients with physical disability,
and easy access to the hospital by public transport.
HCPs also suggested higher rank-orders for develop-
mentally appropriate care (e.g., providing transitional
care plan) and for providing easy ways to contact the
service with timely responses, which were ranked
relatively low by YP.
Moreover, HCPs agreed to remove 18 out of the 105
question items that are likely to generate the same
responses from all services, and hence are not discrimin-
atory. These include whether or not services provide
blood monitoring for anti-inflammatory treatments and
whether or not services send out clinic letters to
patients. Forty-seven items were kept without revision
and 40 items were either clarified to improve under-
standing or reworded to better identify challenges and
issues with care provision. HCPs also discussed differ-
ences between adult and adolescent/paediatric care, and
how the final item pool needs to account for these varia-
tions. As a result, two additional response items were
added for services seeing YP under the age of 16, which
are whether services provide educational information
and resources to parents/carers and whether service pol-
icies (e.g., discharge policy) are explained to parents/
carers. The revised toolkit at this stage contained 30
criteria with 89 question items for paediatric services
seeing YP under 16 years old, and 87 response items for
services seeing YP who are 16 years old or older
(Fig. 5). Out of these 30 criteria, YP selected 11
criteria to be included in the YP version of the toolkit
(see Additional file 4). These modifications were
discussed with YP during phase 4.
Lastly, HCPs agreed with the need for a YP facing ver-
sion of the toolkit in order to address problems with
care identified from both patients’ and providers’ per-
spectives. Both versions have similar structures with
three levels of assessment. Level one includes overarch-
ing domains made up of individual criteria (level 2),
which are assessed using different question items (level
3). The overarching domains from level 1 are: assess-
ment and treatment, information and involvement,
accessibility and environment, and continuity of care.
Phase 4: Developing a weighted scoring system
Seven FGs with 27 YP (n1 = 5, n2 = 3, n3 = 3, n4 = 4,
n5 = 4, n6 = 5, n7 = 3) from four cities across the UK
and 5 one-to-one interviews with parents/carers of YP
were conducted. Participants from this phase discussed
the final criteria and question items, and agreed with
almost all adaptations made by HCPs in phase 3. YP
were also asked to complete the 1000minds programme
collaboratively as a group during each FG. They were
presented with an average of 156 pairwise-ranking for
the HCP version, and an average of 78 pairwise-ranking
for the YP version.
The mean preference values (derived using 1000minds)
from all 7 FGs ranged from 0.3 to 6.2 for the HCP version
in which 0.3 reflected the lowest and 6.2 the highest im-
portance (see Additional file 5). For the YP version, the
mean preference values ranged from 3.7 to 13.9 (see Add-
itional file 4). Intra-class correlation estimates of these
preference values based on mean-rating of the FGs (k = 7),
absolute agreement, and 2-way random-effects model
were high (0.89), indicating good agreement between YP
regarding the priority weighting given to these items. A
preliminary scoring system based on the mean preference
values was developed. This scoring approach across mul-
tiple domains allows for a good score in one domain to
compensate for a poor score in another domain.
Phase 5: Face validity and usability of the toolkit
YP version Overall, CIs with YP (n = 28) showed that
they were able to respond to the items without
assistance and believed that the toolkit is easy to under-
stand and feasible to complete (< 2 min) without
compromising its comprehensiveness. YP suggested to
replace the word “doctor” with “rheumatology team
member” and also preferred a binary yes/no response
format instead of a continuous scale. A “not relevant for
my care” response option was added as well. In terms of
the time frame, all YP suggested that answering the
toolkit for their experiences every 6 months would be
appropriate. Lastly, toolkit readability as measured using
the Flesch-Kincaid Grade Level provided by Microsoft
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Word was 5.2, indicating that the toolkit is easily under-
stood by YP aged 10 and above [40].
HCP version CIs with HCPs (n = 7) demonstrated that
the toolkit was completed with ease within a reasonable
amount of time (15 min), and that it captured all essen-
tial quality indicators. HCPs suggested that it would be
useful and feasible to complete the toolkit annually.
Most participants demonstrated high understanding of
the questions, were able to follow instructions appropri-
ately, and could easily retrieve answers to each question.
HCPs were asked to paraphrase certain question items
in their own words and minor improvements were made
by adapting terminologies that are commonly used by
HCPs. In addition, an “other” option was added for
multiple choice questions as well as an option to enter
free-text responses.
Discussion
This report describes a highly consensus-based method-
ology underpinning the development of BeTAR, a
benchmarking toolkit for adolescent and young adult
rheumatology services. The conceptual model of devel-
opmentally appropriate rheumatology services that
emerged from previous work was further explored
through discussions and interviews with stakeholders,
which facilitated the identification of key quality mea-
sures to include in the toolkit. We worked in close
collaboration with YP with chronic inflammatory rheum-
atic diseases in all phases of this study in order to confi-
dently capture the multitude of service areas that truly
reflect what YP want and need. Combining previous
guidelines and recommendations for YP-care with new
criteria derived by YP helped develop a list of items to
characterize and assess service experience, and evaluate
service provision in a comprehensive and YP-relevant
way. Moreover, the YP version of the toolkit can encour-
age sustained engagement and involvement from YP,
which is central to making real, constructive changes to
the provision of care [41, 42].
Two additional key features of BeTAR are that it is
widely applicable and that it can generate a quantitative
score. First, instead of focusing only on transitional [19]
or specialised medical care [21], BeTAR can be seen as
Fig. 5 Categories and criteria for the HCP version; preference values are presented in parentheses
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one overarching toolkit that covers all aspects of
rheumatology-specific needs for YP. The toolkit is also
designed to be used across all rheumatology services that
are seeing YP, regardless of whether they are in a paedi-
atric or adult setting. Second, each criterion was
assigned a weighted score based on their relative prior-
ities for YP. The items in the current toolkit can there-
fore facilitate auditing and assessing performance levels,
and to more easily identify gaps in performance, monitor
progress, and realise opportunities for improvement in
rheumatology services. Implementation of the proposed
toolkit should thus facilitate investigations of variability
between services and across networks, identify current
levels of care and inspire future quality improvement
programmes for YP with rheumatic diseases.
The application of BeTAR into clinical care will
require a staged approach. The first step will be an initial
data collection exercise evaluating adolescent and young
adult rheumatology services across the UK and in the
next phase internationally. This data collection phase
will assess how well the standards are being met in
terms of the quality, outcome, and experience of care for
YP and how these relate to health outcomes. Describing
and understanding current clinical practice through this
process will enable services to target areas of poor
performance and improve clinical care. We anticipate
that the overall process can additionally facilitate effect-
ive quality assessment for service commissioning. For
instance, in diabetes care there is evidence that invest-
ment in regional networks and the introduction of a Best
Practice Tariff mandating participation in audit and
benchmarking evaluation of services has resulted in im-
provements in outcome [43, 44]. This could also be the
case for YP-friendly rheumatology services.
Even though we made an effort to establish the wider
views of YP and HCPs by extending the exercise to
several centres, we cannot exclude that responder bias
may have influenced the views expressed. For example,
we were only able to include clinical nurse specialists
and physiotherapists in our sample, which may have
limited the scope of the toolkit to represent the views of
other allied HCPs such as psychologists and occupa-
tional therapists. In addition, although participation rate
was high (92%) and we aimed to recruit participants
from diverse ethnic backgrounds, translation services
were not offered to participants; it is therefore possible
that some families refused to participate due to a lack of
command of English.
Moreover, ranking of criteria by YP could vary greatly
between different healthcare systems and access to treat-
ments from different parts of the world. It is possible
that some of the items removed from the current toolkit
for UK-based rheumatology services could be relevant in
non-UK settings and may need to be considered further
during the next steps of an international validation exer-
cise. We also acknowledge that quality measures may
change over time and therefore regular re-evaluation of
the toolkit content is required. In addition, collecting
data in itself is not adequate and the data must be
utilized to actually deliver the change needed to drive
quality improvements. This requires a concerted effort
and commitment from both HCPs and YP, as well as in-
put and involvement from healthcare managers. Thus
our long-term goal is to establish a fit-for-purpose IT
system, where the toolkit can be accessed electronically
by service providers and HCP. This interactive portal
(already under development) will not only allow for
visual comparative evaluation against other hospital
trusts, but will also refer to published resources and
recommendations, foster information sharing and
collaborative learning and thus allow individual centres
to improve their services.
Conclusions
In summary, through a multistage process involving
several FGs, interviews, consensus meetings, and rating
exercises, we developed a toolkit to benchmark and
evaluate YP rheumatology services. Improved service
delivery at local (trust), regional (clinical networks), UK
wide, and international levels against these important
criteria will likely identify potential areas for healthcare
quality improvement, which is key to ensuring positive
clinical outcomes for young people living with chronic
rheumatic diseases.
Additional files
Additional file 1: Toolkit development focus group guide. (DOCX 20 kb)
Additional file 2: Cognitive interview. (DOCX 17 kb)
Additional file 3: Summary of previously established standards and
additional standards proposed by YP. (DOCX 17 kb)
Additional file 4: YP toolkit, with scores for each criterion presented in
parentheses. These are derived from the average preference values from
the 1000minds decision-making software. A higher preference value
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